Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

David Pierce, Mary Corcoran, Patrick Martin, Karen Barrett, Susi Inglis, Peter Preston, Thomas Thompson, Sandra Willsie
  • Drug Design Development and Therapy, May 2014, Dove Medical Press
  • DOI: 10.2147/dddt.s55373
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr David Montague Pierce

In partnership with: